Prothena Corp Public (PRTA) Amortization of Deferred Charges (2021 - 2026)

Prothena Corp Public's (PRTA) quarterly Amortization of Deferred Charges came in at $734000.0 in Q1 2026, up 7.0% year-on-year from $686000.0 in Q1 2025, and up 1.38% quarter-over-quarter from $724000.0 in Q4 2025.

Prothena Corp Public (PRTA) Amortization of Deferred Charges (2021 - 2026) Analysis & Trends

Prothena Corp Public's Amortization of Deferred Charges history runs 6 years deep, the most recent figure standing at $734000.0 for Q1 2026.

  • On a quarterly basis, Amortization of Deferred Charges rose 7.0% year-over-year to $734000.0 in Q1 2026; TTM through Mar 2026 was $2.9 million, a 5.51% increase from a year earlier, with the FY2025 full-year figure at $2.8 million, up 4.27% from the prior year.
  • Amortization of Deferred Charges rose to $734000.0 in Q1 2026 per PRTA's latest filing, from $724000.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $2.3 million in Q4 2023 and bottomed at $662000.0 in Q2 2024.
  • The 5-year median for Amortization of Deferred Charges is $734000.0 (2026), against an average of $1.2 million.
  • Across the five-year window, Amortization of Deferred Charges soared 47.81% in 2023 and sank 69.42% in 2024, its largest moves.
  • Year by year, Amortization of Deferred Charges stood at $1.5 million in 2022, then surged by 47.81% to $2.3 million in 2023, then sank by 69.42% to $692000.0 in 2024, then climbed by 4.62% to $724000.0 in 2025, then grew by 1.38% to $734000.0 in 2026.
  • Per Business Quant, the three latest PRTA Amortization of Deferred Charges figures stand at $734000.0 (Q1 2026), $724000.0 (Q4 2025), and $714000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Prothena Corp Public 458.13 Mn 128.67 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 734,000.00
Mar 31, 2026 734,000.00
Dec 31, 2025 724,000.00
Dec 31, 2025 724,000.00
Sep 30, 2025 714,000.00
Sep 30, 2025 714,000.00
Jun 30, 2025 683,000.00
Jun 30, 2025 683,000.00
Mar 31, 2025 686,000.00
Mar 31, 2025 686,000.00
Dec 31, 2024 692,000.00
Dec 31, 2024 692,000.00
Sep 30, 2024 666,000.00
Sep 30, 2024 666,000.00
Jun 30, 2024 662,000.00
Jun 30, 2024 662,000.00
Mar 31, 2024 672,000.00
Mar 31, 2024 672,000.00
Dec 31, 2023 2.26 Mn
Dec 31, 2023 2.26 Mn